Moderate to severe pain: 5-20 mg, 4 hrly. Extended-release: 5-20 mg 12 hrly.
Pain associated w/ MI: 5-10 mg at 1-2 mg/min followed by a further 5-10 mg as necessary.
Acute pulmonary oedema: 5-10 mg via slow injection at 2 mg/min.
Moderate to severe pain. Initially, 5 mg epidural inj, then 1-2 mg after 1 hr up to a total dose of 10 mg/24 hr, if pain relief is unsatisfactory.
Moderate to severe pain: 0.2-1 mg once daily, up to 20 mg/day as necessary.
Moderate to severe pain: 5-20 mg
Moderate to severe pain: 2.5-10 mg via slow injection over 4-5 min or a starting dose of 1-2 mg/hr via continuous infusion (max: 100 mg/day; 4 g/day in cancer patients).
Severe pain: 10-20 mg 4 hrly.
Adverse drug reactions
: nausea, vomiting, constipation, abdominal pain, dry mouth, anorexia, taste disturbance, dyspepsia, resp depression, sedation, dizziness, confusion, insomnia, headache, somnolence, involuntary muscle contractions, hyperhidrosis, rash, pruritus, asthenic conditions, HTN, bronchospasm, seizures, amenorrhoea, rhabdomyolysis, nystagmus.
See Instructions and conversion table
and Opioid dose conversions
Adapted from CIMS Drug Information System. Internet. Accessed on January 10, 2016.